pneumonia

Roche’s Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Severe COVID-19 Pneumonia

  • by

Shots: The P-III REMDACTA study involves assessing Actemra/RoActemra (tocilizumab) + Veklury (remdesivir) vs PBO + Veklury in hospitalized patients with severe COVID-19 pneumonia receiving SOC The study did not meet its 1EPs i.e. improvement in time to hospital discharge up to day28 and failed to… Read More »Roche’s Actemra/RoActemra (tocilizumab) + Veklury Fail to Meet its Primary Endpoints in P-III REMDACTA Study for Patients with Severe COVID-19 Pneumonia

Mobile Point-of-Care Ultrasound Is Now A Frontline Warrior in Pandemic

  • by

Diku Mandavia, M.D., SVP, Chief Medical Officer at FUJIFILM Sonosite Health authorities need to prioritize delivery and the repurposing of mobile point-of-care ultrasound machines which have proven to be reliable, affordable, and effective in saving the lives of coronavirus patients.   Most Americans are familiar with… Read More »Mobile Point-of-Care Ultrasound Is Now A Frontline Warrior in Pandemic

Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap

  • by

Oliver Schacht, PhD, CEO of OpGen Secondary bacterial or fungal co-infections in COVID-19 patients have received inadequate attention from the public. For most, co-infections pose little to no risk according to reports that an estimated 8% of patients are found to experience this during hospital admission – a… Read More »Super-Spreading of COVID-19 Co-Infections Reveals a Deadly Diagnostics Gap